Literature DB >> 1061157

Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

K Illmensee, B Mintz.   

Abstract

A definitive test for developmental totipotency of mouse malignant teratocarcinoma cells was conducted by cloning singly injected cells in genetically marked blastocysts. Totipotency was conclusively shown in an adult mosaic female whose tumor-strain cells had made substantial contributions to all of the wide range of its somatic tissues analyzed; the clonally propagated cell lineage had therefore differentiated in numerous normal directions. The test cells were from "cores" of embryoid bodies of a euploid, chromosomally male (X/Y), ascites tumor grown only in vivo by transplantation for 8 years. The capacity of cells from the same source to differentiate, in a phenotypic male, into reproductively functional sperms, has been shown in our previous experiments [(1975) Proc. Nat. Acad. Sci. USA 72, 3585-3589]. Cells from this transplant line therefore provide material suitable for projected somatic and germ-line genetic analyses of mammalian differentiation based on "cycling" of mutation-carrying tumor cells through developing embryos. In some animals obtained from single-cell injections tumor-derived cells were sporadically distributed in developmentally unrelated tissues. These cases can be accounted for by delayed and haphazard cellular integration, and by a marked degree of sustained cellular developmental flexibility in early mammalian development, irrespective of certain classical "germ-layer" designations. All mosaic mice obtained have thus far been free of teratomas. In one case, the injected stem cell contributed only to the pancreas and gave rise to a malignancy resembling pancreatic adenocarcinoma. The high modal frequency of euploidy in these individually tested cells thus tends to indicate that a near-normal chromosome complement is sufficient for total restoration of orderly gene expression in a normal embryonic environment; it may also be necessary for teratoma stem-cell proliferation to be terminated there.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1061157      PMCID: PMC335947          DOI: 10.1073/pnas.73.2.549

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Determination of sex of teratomas derived from early mouse embryos.

Authors:  G R Dunn; L C Stevens
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Fate of teratocarcinoma cells injected into early mouse embryos.

Authors:  V E Papaioannou; M W McBurney; R L Gardner; M J Evans
Journal:  Nature       Date:  1975-11-06       Impact factor: 49.962

3.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.

Authors:  L J KLEINSMITH; G B PIERCE
Journal:  Cancer Res       Date:  1964-10       Impact factor: 12.701

Review 4.  Gene control of mammalian differentiation.

Authors:  B Mintz
Journal:  Annu Rev Genet       Date:  1974       Impact factor: 16.830

5.  Enzyme histochemistry of experimental embryo-derived teratocarcinomas.

Authors:  I Damjanov; D Solter; N Skreb
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

6.  Investigation on the origin of the definitive endoderm in the rat embryo.

Authors:  B Levak-Svajger; A Svajger
Journal:  J Embryol Exp Morphol       Date:  1974-10

7.  Clonal origins of somites and their muscle derivatives: evidence from allophenic mice.

Authors:  J D Gearhart; B Mintz
Journal:  Dev Biol       Date:  1972-09       Impact factor: 3.582

Review 8.  The biology of teratomas.

Authors:  L C Stevens
Journal:  Adv Morphog       Date:  1967

9.  Microinjection of mouse eggs.

Authors:  T P Lin
Journal:  Science       Date:  1966-01-21       Impact factor: 47.728

10.  The effect of cells transferred into the mouse blastocyst on subsequent development.

Authors:  R L Brinster
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  123 in total

Review 1.  The relation of gene control mechanisms to cancer.

Authors:  H Busch
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-09-28

Review 2.  Embryonic stem cells.

Authors:  H J Rippon; A E Bishop
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

3.  Reprogramming human cancer cells in the mouse mammary gland.

Authors:  Karen M Bussard; Corinne A Boulanger; Brian W Booth; Robert D Bruno; Gilbert H Smith
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

4.  Heart tumors specifically induced in young avian embryos by the v-myc oncogene.

Authors:  S Saule; J P Mérigaud; A E Al-Moustafa; F Ferré; P M Rong; P Amouyel; B Quatannens; D Stéhelin; F Dieterlen-Lièvre
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells.

Authors:  B W Booth; C A Boulanger; L H Anderson; G H Smith
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

6.  What history tells us VII. Twenty-five years ago: the production of mouse embryonic stem cells.

Authors:  Michel Morange
Journal:  J Biosci       Date:  2006-12       Impact factor: 1.826

Review 7.  Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.

Authors:  Adriane Regina Todeschini; Sen-itiroh Hakomori
Journal:  Biochim Biophys Acta       Date:  2007-10-22

Review 8.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

9.  The hormetic morphogen theory of curvature and the morphogenesis and pathology of tubular and other curved structures.

Authors:  Egil Fosslien
Journal:  Dose Response       Date:  2009-10-16       Impact factor: 2.658

10.  Studies of teratomas in mice: possibilities for the future production of animal models.

Authors:  J M Lehman
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.